How long does it take for platinib treatment to show obvious effects?

Pralsetinib is a targeted drug mainly used to treat non-small cell lung cancer (NSCLC) and certain other types of cancer with RET gene mutations. As a targeted therapy drug, the therapeutic effect of platinib usually takes a certain amount of time to appear. The specific effect time varies depending on individual differences and disease types. The following is a time prediction and related analysis of the therapeutic effect of platinib.

As a targeted drug, some patients may begin to feel the initial effects of the treatment within a few weeks to a month in the early stages of treatment. According to clinical studies, some patients may experience symptom relief within a few weeks after receiving platinib treatment, especially tumor-related symptoms such as cough and chest pain. However, the time it takes for these effects to appear varies depending on the patient's constitution, stage and severity of the disease, so some patients may take longer to see noticeable results.

Platinib treatment usually requires imaging examinations to evaluate the effect after about 2 months. According to clinical research data, most patients will have obvious tumor shrinkage or stabilization after two months of treatment. For patients with non-small cell lung cancer who have mutations in the RET gene, platinib can often inhibit further tumor growth and reduce tumor size. During this time, patients' disease progression often slows, and some patients may even achieve partial remission.

For long-term effects of platinib, most patients will need to receive treatment for at least 3 to 6 months. After a longer period of continuous treatment, the patient's tumor status may further improve, and even complete remission or sustained stable effects may occur in some patients. When using platinib long-term, patients will need regular imaging and blood tests to evaluate the drug's effectiveness and possible side effects. Therefore, the effects of treatment are usually more noticeable after 3 to 6 months.

It is worth noting that the therapeutic effect of platinib is affected by individual differences among patients. Some patients may see significant results early in treatment, while others may experience longer treatment to achieve desired results. In addition, as treatment progresses, the effect may gradually weaken for some patients due to drug resistance or other reasons. Therefore, patients need to communicate with their doctors regularly to ensure the effectiveness of the treatment plan and adjust treatment strategies in a timely manner.

Reference materials:https://gavreto.com/